Back
Biomarin Pharmaceutical Quote, Financials, Valuation and Earnings
Sponsored
BMRN
Sponsored
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.43
Seasonality Move:
5.7%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock marketBiomarin Pharmaceutical Price Quote
$71.43
+0.29 (+0.41%)
(Updated: September 19, 2024 at 6:50 PM ET)
Biomarin Pharmaceutical Key Stats
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Day range:
$70.11 - $71.58
52-week range:
$68.83 - $99.56
Dividend yield:
0%
P/E ratio:
81.77
P/S ratio:
5.36
P/B ratio:
2.56%
Volume:
2.2M
Avg. volume:
2M
1-year change:
-19.71%
Market cap:
$13.5B
Revenue:
$2.4B
EPS:
$1.33
How Much Does Biomarin Pharmaceutical Make?
-
How Much Are Biomarin Pharmaceutical's Sales Annually?
BMRN Revenues are $2.4B -
How Much Profit Does Biomarin Pharmaceutical's Make A Year?
BMRN net income is $167.6M
Is Biomarin Pharmaceutical Growing As A Company?
-
What Is Biomarin Pharmaceutical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.2% -
What Is Biomarin Pharmaceutical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.9%
Biomarin Pharmaceutical Stock Price Performance
-
Did Biomarin Pharmaceutical Stock Go Up Last Month?
Biomarin Pharmaceutical share price went down by -20.54% last month -
Did BMRN's Share Price Rise Over The Last Year?
BMRN share price fell by -19.71% over the past 1 year
What Is Biomarin Pharmaceutical 52-Week High & Low?
-
What Is Biomarin Pharmaceutical’s 52-Week High Share Price?
Biomarin Pharmaceutical has traded as high as $99.56 over the past 52 weeks -
What Is Biomarin Pharmaceutical’s 52-Week Low Share Price?
Biomarin Pharmaceutical has traded as low as $68.83 over the past 52 weeks
Biomarin Pharmaceutical Price To Free Cash Flow
-
Is Biomarin Pharmaceutical Stock Overvalued?
Biomarin Pharmaceutical is trading at a price to free cash flow ratio of 65.14 -
Is Biomarin Pharmaceutical Stock Undervalued?
Biomarin Pharmaceutical EV to Free Cash Flow ratio is 63.01 -
What Is Biomarin Pharmaceutical’s Price Earnings Growth Ratio?
BMRN PEG ratio is 0.34 -
Is Biomarin Pharmaceutical Trading At A Premium To Earnings?
Biomarin Pharmaceutical EV to EBIT ratio is 42.56
Is It Risky To Buy Biomarin Pharmaceutical?
-
How Much Debt Does Biomarin Pharmaceutical Have?
Total long term debt quarterly is $1.1B -
How Much Cash Does Biomarin Pharmaceutical Have?
Cash and short term investments quarterly total is $1.2B -
What Is Biomarin Pharmaceutical’s Book Value Per Share?
Book value per share is 27.77
Is Biomarin Pharmaceutical Cash Flow Positive?
-
What Is BMRN Cash Flow From Operations?
Cash flow from operations (TTM) is $328.9M -
What Is Biomarin Pharmaceutical’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$20.1M -
What Is Biomarin Pharmaceutical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$34.5M
Biomarin Pharmaceutical Return On Invested Capital
-
Is Management Doing A Good Job?
BMRN return on invested capital is 4.22% -
What Is Biomarin Pharmaceutical Return On Assets?
ROA measures how assets are converting to revenues and is 3.76% -
What Is BMRN Return On Equity?
ROE is a measure of profitability and is 5.13%
Biomarin Pharmaceutical Earnings Date & Stock Price
-
What Is Biomarin Pharmaceutical's Stock Price Today?
A single share of BMRN can be purchased today for 71.14 -
What Is Biomarin Pharmaceutical’s Stock Symbol?
Biomarin Pharmaceutical trades on the nasdaq under the ticker symbol: BMRN -
When Is Biomarin Pharmaceutical’s Next Earnings Date?
The next quarterly earnings date for Biomarin Pharmaceutical is scheduled on November 1, 2024 -
When Is BMRN's next ex-dividend date?
Biomarin Pharmaceutical's next ex-dividend date is September 20, 2024 -
How To Buy Biomarin Pharmaceutical Stock?
You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Biomarin Pharmaceutical Competitors
-
Who Are Biomarin Pharmaceutical's Competitors?
Below is a list of companies who compete with Biomarin Pharmaceutical or are related in some way:
Biomarin Pharmaceutical Dividend Yield
-
What Is BMRN Dividend Yield?
Biomarin Pharmaceutical’s dividend yield currently is 0% -
What Is Biomarin Pharmaceutical’s Payout Ratio?
Biomarin Pharmaceutical’s payout ratio is 0% -
When Did Biomarin Pharmaceutical Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Biomarin Pharmaceutical’s Dividend Per Share?
Biomarin Pharmaceutical pays a dividend of $0.00 per share
Biomarin Pharmaceutical Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 89.66% | 60.99% |
Revenue: | 19.61% | 7.23% |
Analyst Recommendations
Buy Recommendations: | 14 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 0 |
Price Target: | 104.74 |
Upside from Last Price: | 47.23% |